English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  51608208    ???header.onlineuser??? :  1198
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"felip e"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-10 of 44  (5 Page(s) Totally)
1 2 3 4 5 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2022-09-15T01:08:57Z Impact of lorlatinib on patient-reported outcomes in patients with advanced ALK-positive or ROS1-positive non-small cell lung cancer Peters S.; Shaw A.T.; Besse B.; Felip E.; Solomon B.J.; Soo R.A.; Bearz A.; Gadgeel S.M.; Chia-Chi Lin; Kao S.; Seto T.; Masters E.T.; Abbattista A.; Clancy J.S.; Thurm H.; Reisman A.; Peltz G.; Ross Camidge D.
臺大學術典藏 2022-09-15T01:08:55Z Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Second-Line Treatment of Patients With NSCLC: Results From an Expansion Cohort of a Phase 1 Trial Paz-Ares L.; Kim T.M.; Vicente D.; Felip E.; Lee D.H.; Lee K.H.; Chia-Chi Lin; Flor M.J.; Di Nicola M.; Alvarez R.M.; Dussault I.; Helwig C.; Ojalvo L.S.; Gulley J.L.; Cho B.C.
臺大學術典藏 2022-08-10T02:37:40Z Has COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) Survey Garrido P.; Adjei A.A.; Bajpai J.; Banerjee S.; Berghoff A.S.; Choo S.P.; Felip E.; Furness A.J.S.; Garralda E.; Haanen J.; Letsch A.; Linardou H.; Peters S.; Sessa C.; Tabernero J.; Tsang J.; CHIH-HSIN YANG; Garassino M.C.
臺大學術典藏 2022-08-10T02:37:38Z Female leadership in oncology�Xhas progress stalled? Data from the ESMO W4O authorship and monitoring studies Berghoff A.S.; Sessa C.; CHIH-HSIN YANG; Tsourti Z.; Tsang J.; Tabernero J.; Peters S.; Linardou H.; Letsch A.; Haanen J.; Garralda E.; Garassino M.C.; Furness A.J.S.; Felip E.; Dimopoulou G.; Dafni U.; Choo S.P.; Banerjee S.; Bajpai J.; Adjei A.A.; Garrido P.
臺大學術典藏 2022-08-10T02:37:38Z Treatment Outcomes and Safety of Mobocertinib in Platinum-Pretreated Patients with EGFR Exon 20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer: A Phase 1/2 Open-label Nonrandomized Clinical Trial Zhou C.; Ramalingam S.S.; Kim T.M.; Kim S.-W.; CHIH-HSIN YANG; Riely G.J.; Mekhail T.; Nguyen D.; Garcia Campelo M.R.; Felip E.; Vincent S.; Jin S.; Griffin C.; Bunn V.; Lin J.; Lin H.M.; Mehta M.; J?nne P.A.
臺大學術典藏 2022-08-10T02:37:38Z Brigatinib Versus Crizotinib in ALK Inhibitor�VNaive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L Trial Camidge D.R.; Kim H.R.; Ahn M.-J.; CHIH-HSIN YANG; Han J.-Y.; Hochmair M.J.; Lee K.H.; Delmonte A.; Garcia Campelo M.R.; Kim D.-W.; Griesinger F.; Felip E.; Califano R.; Spira A.I.; Gettinger S.N.; Tiseo M.; Lin H.M.; Liu Y.; Vranceanu F.; Niu H.; Zhang P.; Popat S.
臺大學術典藏 2022-06-27T06:59:45Z Final Overall Survival and Other Efficacy and Safety Results From ASCEND-3: Phase II Study of Ceritinib in ALKi-Naive Patients With ALK-Rearranged NSCLC Nishio M.; Felip E.; Orlov S.; Park K.; CHONG-JEN YU; Tsai C.-M.; Cobo M.; McKeage M.; Su W.-C.; Mok T.; Scagliotti G.V.; Spigel D.R.; Viraswami-Appanna K.; Chen Z.; Passos V.Q.; Shaw A.T.
臺大學術典藏 2022-06-27T06:59:36Z Olmutinib in T790M-positive non–small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 study Park K.; J?nne P.A.; Kim D.-W.; Han J.-Y.; Wu M.-F.; Lee J.-S.; Kang J.-H.; Lee D.H.; Cho B.C.; CHONG-JEN YU; Pang Y.K.; Felip E.; Kim H.; Baek E.; Noh Y.S.
國立成功大學 2022 Phase Ib/II study of ceritinib in combination with ribociclib in patients with ALK-rearranged non–small cell lung cancer Santoro, A.;Su, W.-C.;Navarro, A.;Simonelli, M.;CH, Yang J.;Ardizzoni, Ardizzoni A.;Barlesi, F.;Hyoung, Kang J.;DiDominick, S.;Abdelhady, Abdelhady A.;Chen, X.;Stammberger, U.;Felip, E.
國立成功大學 2022 Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer Gupta, S.;Strohbehn, I.A.;Wang, Q.;Hanna, P.E.;Seethapathy, R.;Prosek, J.M.;Herrmann, S.M.;Abudayyeh, Abudayyeh A.;Malik, A.B.;Loew, S.;Carlos, Carlos C.A.;Chang, W.-T.;Beckerman, P.;Mithani, Z.;Shah, C.V.;Renaghan, A.D.;de, Seigneux S.;Campedel, L.;Kitchlu, A.;Shin, D.S.;Coppock, G.;Lumlertgul, N.;Garcia, P.;Ortiz-Melo, D.I.;Rashidi, A.;Sprangers, B.;Aggarwal, V.;Benesova, K.;Jhaveri, K.D.;Cortazar, F.B.;Weins, A.;Zuo, Y.;Mooradian, Mooradian M.J.;Reynolds, K.L.;Leaf, D.E.;Sise, M.E.;Salem, J.-E.;Bagnis, C.I.;Singh, H.;Motwani, S.S.;Murakami, N.;Tio, M.C.;Mothi, S.S.;Selamet, U.;Schmidt-Ott, K.M.;Chang, W.;Wanchoo, R.;Khanin, Y.;Hirsch, J.S.;Sakhiya, V.;Stalbow, D.;Wu, S.;Ostermann, M.;Seylanova, N.;Cennamo, A.;Rigg, A.;Shaunak, N.;Kibbelaar, Z.A.;Deshpande, P.;Seethapathy, H.S.;Lee, M.;Strohbhen, I.A.;Isik, B.;Glezerman, I.G.;Chandra, S.;Madhavan, S.M.;Owen, D.H.;Husain, M.;Mini, S.;Anand, S.;Kaghazchi, A.;Rangarajan, S.;Cherry, G.;Hsu, R.K.;Kisel, A.;Kansal, S.K.;Albert, N.;Carter, K.;Donley, V.;Young, T.;Cigoi, H.;Koessler, T.;Wauters, E.;Eijgelsheim, M.;Pagan, J.A.;Hogan, J.J.;Mamlouk, O.;Lin, J.S.;Page, V.;Short, Short S.A.P.;Gaughan, E.M.;Soler, M.J.;Garc�a-Carro, Carro C.;Bermejo, S.;Felip, E.;Mu�oz-Couselo, E.;Carreras, M.J.;Consortium, ICPi-AKI

Showing items 1-10 of 44  (5 Page(s) Totally)
1 2 3 4 5 > >>
View [10|25|50] records per page